Skip to main content

Table 4 Results of screening by Five Year Age Strata: Safety Check and Intervention arms

From: A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

 

Safety Check Arm

Intervention Arm

Age Strata

hr-HPV Negative (%)

hr-HPV Positive (%)

hr-HPV Unsatis (%)

Total

hr-HPV Negative (%)

hr-HPV Positive (%)

hr-HPV Unsatis (%)

Total

25-29

117 (76.5)

36 (23.5)

0 (0.0)

153

95 (74.8)

31 (24.4)

1 (0.8)

127

30-34

151 (87.8)

21 (12.2)

0 (0.0)

172

146 (88.0)

20 (12.0)

0 (0.0)

166

35-39

284 (90.2)

31 (9.8)

0 (0.0)

315

239 (88.8)

30 (11.2)

0 (0.0)

269

40-44

324 (92.3)

26 (7.4)

1 (0.3)

351

300 (94.0)

18 (5.6)

1 (0.3)

319

45-49

358 (96.5)

13 (3.5)

0 (0.0)

371

354 (94.1)

19 (5.1)

3 (0.8)

376

50-54

293 (93.9)

18 (5.8)

1 (0.3)

312

267 (94.3)

15 (5.3)

1 (0.4)

283

55-59

232 (96.3)

9 (3.7)

0 (0.0)

241

265 (95.0)

13 (4.7)

1 (0.4)

279

60+

195 (95.6)

9 (4.4)

0 (0.0)

204

188 (97.4)

4 (2.1)

1 (0.5)

193

Total

1954 (92.2)

163 (7.7)

2 (0.1)

2119

1854 (92.1)

150 (7.5)

8 (0.4)

2012

  1. HPV Digene Negative: Non-reactive for HPV High or Intermediate risk types.
  2. HPV Digene Positive: Reactive for HPV High or Intermediate risk types.
  3. HPV Digene Unsatis: Results unsatisfactory - need to repeat specimen